Elsevier

Journal of Informetrics

Volume 6, Issue 1, January 2012, Pages 131-139
Journal of Informetrics

The relationships between the patent performance and corporation performance

https://doi.org/10.1016/j.joi.2011.09.001Get rights and content

Abstract

This study utilizes panel regression model to explore the relationships between corporate performance and the patent performance measured from patent H index, current impact index (CII), and essential patent index (EPI) in the pharmaceutical company. The results demonstrate that patent H index and EPI have positive influences upon corporate performance. Furthermore, this study developed a classification for the pharmaceutical companies to divide them into four types, and provided some suggestions to them.

Highlights

► We examine the relationships between patent performance and corporate performance. ► Patent performance measured from patent H index, CII, and EPI. ► Market value, ROE, and sales as the proxy variable of corporation performance. ► Patent H index and EPI have positive influences upon corporate performance.

Introduction

Patents, serving as an important output indicator of research and development activities, are widely adopted in researches concerning relationship between patent counts and corporation performance (Bosworth and Rogers, 2001, Comanor and Scherer, 1969, Deng et al., 1999, Scherer, 1965). However, they often fail to offer sufficient information regarding innovation output since that some enterprises may have only a few patents but with high influence, while others may have a lot of patents yet low in influence (Hirschey and Richardson, 2001, Park and Park, 2006). This phenomenon is also known as the skewed distribution of patent value which means that patents with high value and high influence only take a small portion of total patents (Park and Park, 2006, Schankerman and Pakes, 1986).

In light of this, many scholars suggest that patent citations could be used measure the influence of patent. The idea of measuring patent citations is based on the same base in Bibliometrics that the influence of certain publication could be measured by its citation. Therefore, patent citations could also be utilized as a measure of the technological quality and importance of the patent. Through patent citation analysis, fundamental or important patents could be identified in the sense that the more frequent the patent citations is, the higher influence the patent is of, or the more impact or important it possesses (Breitzman et al., 2002, Deng et al., 1999, Narin, 1994, Trajtenberg, 1990).

Trajtenberg (1990) argues that the higher frequency of corporation patent citations is, the more probability that the patents may serve as the fundamental of future patented technology development, and the more influence on technological development it may resume which meantime also may implicate the higher value of the patent (Brown and Svenson, 1998, Jaffe et al., 1993, Narin et al., 1997, Stolpe, 2002, Stuart and Podolny, 1996). Moreover, patent citations could also be used as the measure of corporation R&D output, innovation worth as well as corporation invention performance (Hagedoorn and Cloodt, 2003, Hall et al., 2005, Lanjouw and Schankerman, 2004, Trajtenberg, 1990).

In researches regarding the relationship between patent performance and corporation performances, many scholars have confirmed the positive relation between patent citations and market value in many industries such as manufacturing, pharmaceutical as well as semiconductor industries (Chen and Chang, 2010, Griliches, 1990, Hall et al., 2000, Hall et al., 2005, Lanjouw and Schankerman, 2004, Shane and Klock, 1997). Meanwhile, patent citations is also highly interrelated with profits and sales (Narin, Noma, & Perry, 1987). With patent counts and patent citations etc. as the indicator of corporation technological capacity, Deng et al. (1999) empirical study has further confirmed that the higher patent counts and patent citations are, the better corporation performance (stock return, market-to-book ratio) is. Besides, findings of Harhoff, Narin, Scherer, and Vopel (1999), and Harhoff, Schererc, and Vopeld (2003) also suggest positive relation between patent value and patent citations. Therefore, we can safely draw the conclusion that high patent citations also reflects high knowledge spillover and economic value (Chen and Chang, 2010, Griliches, 1990, Hall, 2000, Harhoff et al., 1999, Jaffe et al., 1993, Stolpe, 2002, Trajtenberg, 1990).

Based on the proposition that patent citations indicator demonstrates technological capacity quality of corporation, this study used three patent citations indicators – patent H index (Guan & Gao, 2009), current impact index (Breitzman & Narin, 2001), and essential patent index (Chen, Lin, & Huang, 2007) to explore their influences upon the corporate performance to fill the research gap. The structure of this paper is as follows: Section 2 would outline the literature review and hypothesis development; Section 3 described the methodology and measurement of this paper; Section 4 would discuss the empirical results; the final section was conclusions and implications of this study.

Section snippets

Literature review and hypothesis development

Hirsch (2005) proposes a new indicator H index as a measure of individual scientist research achievements which is defined as follows: “A scientist has index h if h of his or her Np papers have at least h citations each and the other (Np  h) papers have ≤h citations each (Hirsch, 2005). Just as the H index, Guan and Gao (2009) define the patent H index, the number h such that, for a general group of patents, h patents received at least h citations from later patents, while other patents received

Sample and data collection

The firms selected are the top global sales of prescription drug as indicated by the 2010 Pharm Exec 50. After adjustments for extreme values and missing data, the final sample for analysis consists of 42 public firms and 555 firm-year observations. The panel data containing patent data and financial data of the sample spanned the period from 1996 to 2009. The financial data of this study were obtained from the COMPUSTAT database. The patent data of this study was gathered from the United

Results

The descriptive statistics and correlation matrix of this study were showed in Table 1. According to Table 1, corporation performance (market value, sales, and ROE) is correlated with patent H index, CII, total assets, and R&D expenditures. This study explored the influence of patent H index, CII and EPI on their performance. The dependent variable of this study was market value, sales and ROE, and the independent variables were patent H index, CII and EPI, while the control variables were the

Conclusions and discussion

The objective of this paper was to investigate the influence of patent performance which were patent H index, CII and EPI upon corporation performance in the pharmaceutical industry. The results indicated that patent H index and EPI had a positively effect on the market value, sales and ROE.

This study finding out that patent H index and EPI were positively associated with firms’ market value, sales and ROE in the pharmaceutical industry of global, this study developed a classification for the

Acknowledgements

This work was supported by grants from the Fundamental Research Funds for The Central Universities of China (105273449).

References (36)

  • Breitzman, A. F., & Narin, F. (2001). 6175824 United States...
  • A.F. Breitzman et al.

    Technological powerhouse or diluted competence: Techniques for assessing mergers via patent analysis

    R&D Management

    (2002)
  • M.G. Brown et al.

    Measuring R&D productivity

    Research-Technology Management

    (1998)
  • D.-Z. Chen et al.

    Using essential patent index and essential technological strength to evaluate industrial technological innovation competitiveness

    Scientometrics

    (2007)
  • W.S. Comanor et al.

    Patent statistics as a measure of technical change

    Journal of Political Economy

    (1969)
  • Z. Deng et al.

    Science and technology as predictors of stock performance

    Financial Analysts Journal

    (1999)
  • W.H. Greene

    Simple regression with variable intercepts

    Econometric analysis

    (2003)
  • Z. Griliches

    Patent statistics as economic indicators: A survey

    Journal of Economic Literature

    (1990)
  • Cited by (50)

    • Hawkes process-based technology impact analysis

      2017, Journal of Informetrics
      Citation Excerpt :

      This underpins technology forecasting research such that forthcoming technological changes are foreshadowed by current developments and influenced by changes in related technologies (Watts & Porter, 1997). In this respect, previous studies have employed the citation counts of patents to assess the impact of a given technology on subsequent innovation outcomes (Albert, Avery, Narin, & McAllister, 1991; Carpenter, Narin, & Woolf, 1981; Chakrabarti, 1991;Chang, Chen, & Huang, 2012; Cheng, Kuan, & Chuang, 2010;Choi & Park, 2009; Kim, Lee, Seol, & Lee, 2011). However, the outcomes of previous methods do not provide a fair reflection of a technology’s future prospects since they are based on deterministic approaches, assuming that future trends will remain the same as those in the past (Lee, Cho, Seol, & Park, 2012).

    View all citing articles on Scopus
    View full text